Lanzamiento Enero 2027

Ensayo controlado aleatorizado2018Financiado por la industriaAlimentación controlada

Financiado en parte por Cereal Partners Worldwide

A 12-wk whole-grain wheat intervention protects against hepatic fat: the Graandioos study, a randomized trial in overweight subjects

Schutte S, Esser D, Hoevenaars FPM, Hooiveld GJEJ, Priebe MG, Vonk RJ, Wopereis S, Afman LA

The American journal of clinical nutrition · 62 citas

Etiquetas de revisión

Alimentación controladaFinanciado por la industria

Datos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.

Cómo se estudió

Diseño
Ensayo controlado aleatorizado (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Marcadores de salud y funcionamiento
Consumo medido con
Comida provista por los investigadores

Quién lo pagó

Financiación
Financiado por la industria
Gobierno
European Commission
Gobierno
Seventh Framework Programme
Empresa
Cereal Partners Worldwide
Gobierno
European Commission in the 7th Framework Programme
Subvenciones
Seventh Framework Programme (613979); European Commission (613979)

Según 4 financiadores declarados.

Publicación

Publicado
2018-08-17 · Am J Clin Nutr · vol. 108 · número 6 · págs. 1264–1274
Editorial
Elsevier BV
Citado
73 citas · más que el 96% de estudios similares · 5.3× el promedio de su campo
Impacto
Entre el 10 % más citado de su campo
Referencias
51 trabajos
Acceso
Lectura gratuita
Áreas de investigación
Food composition and properties · Nutritional Studies and Diet · Diet, Metabolism, and Disease
Palabras clave
whole wheat, liver fat, non-alcoholic fatty liver disease, intrahepatic triglyceride, gut microbiota, postprandial triglycerides, serum amyloid A, C-reactive protein, adipose tissue gene expression, overweight adults, postmenopausal women, dietary intervention
MeSH
liver, adipose tissue, feces, humans, triticum, fatty liver, triglycerides, diet, double-blind method, body composition, postmenopause, food handling, dietary fiber, aged, middle aged, netherlands, female, male, adiposity, overweight, lipid metabolism, gastrointestinal microbiome, whole grains

8 autores

  • Sophie Schutte🇳🇱Wageningen University & Research
  • Diederik Esser🇳🇱Wageningen University & Research
  • Femke P. M. Hoevenaars🇳🇱Netherlands Organisation for Applied Scientific Research
  • Guido J. E. J. Hooiveld🇳🇱Wageningen University & Research
  • Marion G. Priebe🇳🇱University Medical Center Groningen; University of Groningen
  • Roel J. Vonk🇳🇱University Medical Center Groningen; University of Groningen
  • Suzan Wopereis🇳🇱Netherlands Organisation for Applied Scientific Research
  • Lydia A. Afman🇳🇱 · autor de correspondenciaWageningen University & Research

Resumen

El texto original del estudio, en el idioma en que se publicó.

Background

Whole-grain wheat (WGW) is described as nutritionally superior to refined wheat (RW) and thus advocated as the healthy choice, although evidence from intervention studies is often inconsistent. The liver, as the central organ in energy metabolism, might be an important target organ for WGW interventions.

Objective

The aim of this study was to investigate the potential benefits of WGW consumption compared with RW consumption on liver health and associated parameters.

Design

We performed a double-blind, parallel trial in which 50 overweight 45- to 70-y-old men and postmenopausal women were randomly allocated to a 12-wk intervention with either WGW (98 g/d) or RW (98 g/d) products. Before and after the intervention we assessed intrahepatic triglycerides (IHTGs) and fat distribution by proton magnetic resonance spectroscopy/magnetic resonance imaging, fecal microbiota composition, adipose tissue gene expression, and several fasting plasma parameters, as well as postprandial plasma lipids after a mixed meal.

Results

Fasting plasma cholesterol, triglycerides, nonesterified fatty acids, and insulin were not affected by RW or WGW intervention. We observed a substantial increase of 49.1% in IHTGs in the RW when compared with the WGW group (P = 0.033). Baseline microbiota composition could not predict the increase in IHTGs after RW, but gut microbiota diversity decreased in the RW group when compared with the WGW group (P = 0.010). In the WGW group, we observed increased postprandial triglyceride levels compared with the RW group (P = 0.020). In addition, the WGW intervention resulted in a trend towards lower fasting levels of the liver acute-phase proteins serum amyloid A (P = 0.057) and C-reactive protein (P = 0.064) when compared to the RW intervention.

Conclusions

A 12-wk RW intervention increases liver fat and might contribute to the development of nonalcoholic fatty liver disease, whereas a 12-wk 98-g/d WGW intervention prevents a substantial increase in liver fat. Our results show that incorporating feasible doses of WGW in the diet at the expense of RW maintains liver health. The study was registered at clinicaltrials.gov as NCT02385149.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.